Evidence in Action: Driving Oncology Asset Valuation for an Informed Investment
Client: Top 10 Pharmaceutical Company Challenge: A healthcare division of a private equity firm was evaluating the acquisition of oncology assets from a…
Client: Top 10 Pharmaceutical Company Challenge: A healthcare division of a private equity firm was evaluating the acquisition of oncology assets from a…
Client: Top 10 Pharmaceutical Company Challenge: A global biopharmaceutical company requested expert support to define a fit-for-purpose early access program (EAP) for an…
Client: Top 10 Pharmaceutical Company Challenge: A large biopharmaceutical company preparing to launch a targeted oncology therapy required assessing the access environment for…
Client: Top 10 Pharmaceutical Company Challenge: A top 10 global biopharmaceutical company aimed to convene a virtual workshop on Real-World Evidence (RWE) with…